藤黄酸
溶解度
渗透(战争)
羟乙基淀粉
纳米颗粒
药品
材料科学
血液循环
纳米技术
药理学
化学
医学
生物化学
有机化学
体外
传统医学
工程类
运筹学
作者
Wanfang Zhu,Ruyi Wang,Fulei Liu,Zongtao Zhang,Xiaoxian Huang,Jiaxin Zhang,Feng Feng,Wenyuan Liu,Wei Qu
标识
DOI:10.1016/j.jddst.2022.103910
摘要
Gambogic acid (GA) has been approved to enter the phase III clinical trial. However, due to its short half-life, low water solubility, poor stability and inflammatory response, GA failed to pass the clinical superiority evaluation. Nano-preparations perform well in prolonging drug half-life, improving drug solubility, and enhancing drug stability etc. Therefore, a self-assembled nanoparticle (GA-HES/NPs) with long circulation and deep tumor penetration ability was designed, in which hydroxyethyl starch (HES) endowed GA-HES/NPs with longer circulation time as well as deep tumor penetration ability, and the simple synthesis method ensured the stability of GA structure. Experimental results showed that GA-HES/NPs owned a certain tumor targeting and deep tumor penetration ability, as well as longer circulation time, which could enhance the therapeutic effect of GA.
科研通智能强力驱动
Strongly Powered by AbleSci AI